Gordon Stewart-Harrison recalls his first experience with chronic obstructive pulmonary disease (COPD ... so I thought I just needed to exercise more.” Knowing the risk factors is also important. The ...

whilst between grades 4 and 5 exercise performance and age were the major determinants. CONCLUSIONS The MRC dyspnoea scale is a simple and valid method of categorising patients with COPD in terms of ...

Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) ...

Distinct patterns of symptom severity among patients with COPD sheds light on the heterogeneous nature of the patients’ ...

N-acetylcysteine (NAC) nebulizer therapy is effective and safe in the short-term (12 weeks) for reducing phlegm in COPD.

The following is a summary of "Determining the Impact of COVID-19 Infection on Patients Hospitalized With COPD Exacerbations: ...

Background Clinical studies have shown that glucagon-like peptide-1 receptor agonists (GLP-1 RA) can have beneficial effects ...

Defining futility in COPD can be especially challenging. A malignancy that has progressed despite a series of treatment regimens can allow patients, physicians, and family to address the issue of ...

Immediately linking chronic obstructive pulmonary disease (COPD) and asthma patients who smoke to an appointment at a smoking cessation clinic significantly improved quit rates, a multicenter trial ...

in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD). Design and Patients: Randomised, double-blind, double-dummy, placebo-controlled study in 123 ...

Chronic obstructive pulmonary disease (COPD) has seen no new therapies brought to market for around 10 years – and now there have been two in the space of a couple of weeks. The European ...